Results
Alivus Life Sciences Q1 FY27 Revenue Up 6.4% YoY
Alivus Life Sciences reported Q1 FY27 revenue of INR640 crore, a 6.4% YoY growth, driven by a 26.5% surge in non-GPL business.
EBITDA margin expanded 650 bps YoY to 36.6%, supported by favorable produ
